Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Pastimes : CNBC -- critique. -- Ignore unavailable to you. Want to Upgrade?

To: Thomas M. who wrote (3730)	9/27/1999 12:49:00 PM
From: Bob Kim	Read Replies (1) \| Respond to of 17683

After hyping ML's call on UBID, CNBC could have at least noted that Blodget started coverage in March with an Accumulate rating and $90 price target when the stock was trading in the $70s. As for the "undervalued" comment, it's interesting that Blodget's company description for Buy-rated AMZN includes: "While we are generally optimistic about AMZN's long-term prospects, we view the stock as overvalued and recommend significant investor caution." (emphasis added)